// App-Quantinova.ai

359.0 : Living with neuroendocrine tumors: Assessing quality of life (QoL) through a mobile application.

Researchers

Presenter

  • Jared Adams

Principal Investigators

  • David Ray

  • Renee Willmon

  • Linda Kaleis

  • Anand Gautam

  • Sonia J. Pulgar

  • A. Dasari

Medical Centers

  • Self Care Catalysts, Toronto, ON, Canada

  • Ipsen Biopharmaceuticals, Inc., Basking Ridge, NJ

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • Canada

  • United States

Companies

  • Ipsen Biopharmaceuti

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Protein Tyrosine Phosphatase, Receptor Type F

Drug/Treatment

  • Lanreotide

  • Octreotide

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved